324 related articles for article (PubMed ID: 15988026)
1. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
[TBL] [Abstract][Full Text] [Related]
2. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
Ghioni P; Bolognese F; Duijf PH; Van Bokhoven H; Mantovani R; Guerrini L
Mol Cell Biol; 2002 Dec; 22(24):8659-68. PubMed ID: 12446784
[TBL] [Abstract][Full Text] [Related]
3. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
Helton ES; Zhu J; Chen X
J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
[TBL] [Abstract][Full Text] [Related]
4. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
5. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.
Helton ES; Zhang J; Chen X
Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962
[TBL] [Abstract][Full Text] [Related]
6. TAp63γ demethylation regulates protein stability and cellular distribution during neural stem cell differentiation.
Fonseca MB; Nunes AF; Morgado AL; Solá S; Rodrigues CM
PLoS One; 2012; 7(12):e52417. PubMed ID: 23251711
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis.
Sayan BS; Sayan AE; Yang AL; Aqeilan RI; Candi E; Cohen GM; Knight RA; Croce CM; Melino G
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10871-6. PubMed ID: 17581882
[TBL] [Abstract][Full Text] [Related]
9. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
[TBL] [Abstract][Full Text] [Related]
10. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
Chen YK; Hsue SS; Lin LM
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
[TBL] [Abstract][Full Text] [Related]
11. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis.
King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC
Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516
[TBL] [Abstract][Full Text] [Related]
12. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.
Celli J; Duijf P; Hamel BC; Bamshad M; Kramer B; Smits AP; Newbury-Ecob R; Hennekam RC; Van Buggenhout G; van Haeringen A; Woods CG; van Essen AJ; de Waal R; Vriend G; Haber DA; Yang A; McKeon F; Brunner HG; van Bokhoven H
Cell; 1999 Oct; 99(2):143-53. PubMed ID: 10535733
[TBL] [Abstract][Full Text] [Related]
14. Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63.
Duijf PH; Vanmolkot KR; Propping P; Friedl W; Krieger E; McKeon F; Dötsch V; Brunner HG; van Bokhoven H
Hum Mol Genet; 2002 Apr; 11(7):799-804. PubMed ID: 11929852
[TBL] [Abstract][Full Text] [Related]
15. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
Dohn M; Zhang S; Chen X
Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
[TBL] [Abstract][Full Text] [Related]
16. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.
Serber Z; Lai HC; Yang A; Ou HD; Sigal MS; Kelly AE; Darimont BD; Duijf PH; Van Bokhoven H; McKeon F; Dötsch V
Mol Cell Biol; 2002 Dec; 22(24):8601-11. PubMed ID: 12446779
[TBL] [Abstract][Full Text] [Related]
17. Itch/AIP4 associates with and promotes p63 protein degradation.
Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V
Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923
[TBL] [Abstract][Full Text] [Related]
18. Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene.
Sbisà E; Mastropasqua G; Lefkimmiatis K; Caratozzolo MF; D'Erchia AM; Tullo A
Cell Cycle; 2006 Jan; 5(2):205-12. PubMed ID: 16410722
[TBL] [Abstract][Full Text] [Related]
19. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.
McGrath JA; Duijf PH; Doetsch V; Irvine AD; de Waal R; Vanmolkot KR; Wessagowit V; Kelly A; Atherton DJ; Griffiths WA; Orlow SJ; van Haeringen A; Ausems MG; Yang A; McKeon F; Bamshad MA; Brunner HG; Hamel BC; van Bokhoven H
Hum Mol Genet; 2001 Feb; 10(3):221-9. PubMed ID: 11159940
[TBL] [Abstract][Full Text] [Related]
20. Regulatory domain of protein stability of human P51/TAP63, a P53 homologue.
Osada M; Inaba R; Shinohara H; Hagiwara M; Nakamura M; Ikawa Y
Biochem Biophys Res Commun; 2001 May; 283(5):1135-41. PubMed ID: 11355891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
